Results 21 to 30 of about 46,583 (263)

The Effect of Atenolol on CK-MB Levels in Hypertensive Patients

open access: yesIraqi Journal of Pharmaceutical Sciences, 2017
Atenolol is one of beta-adrenergic receptor blocking agent. It is widely used for the treatment of hypertension as a selective antihypertensive drug. But long term usage of atenolol may cause one of the cardiovascular diseases like myocardial infarction.
Inaam A. Amin
doaj   +3 more sources

Economic evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost-effective compared to an atenolol-based regimen [PDF]

open access: yes, 2007
Copyright © 2010 BMJ Publishing Group Ltd & British Cardiovascular Society. Internal or personal use of this material is permitted. However, permission to reprint/republish this material must be obtained from the Publisher.Objective: To compare the cost ...
B Dahlof   +8 more
core   +1 more source

The protective impact of vitamin E against atenolol effect on Ca+2, Testosteron and FSH in male rats

open access: yesKufa Journal for Veterinary Medical Sciences, 2016
Background and objective: Atenolol is β1-selective antagonist nonetheless this selectivity is not absolute and at higher dosages atenolol represses β-2 Adrenoceptors mainly located in bronchial and vascular musculature, alsoβ-blocker atenolol effects on ...
Safa M. Abbas, Luma W. Khalil
doaj   +1 more source

Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia [PDF]

open access: yes, 2016
The concentrations of 12 pharmaceutical compounds (atenolol, erythromycin, cyclophosphamide, paracetamol, bezafibrate, carbamazepine, ciprofloxacin, caffeine, clarithromycin, lidocaine, sulfamethoxazole and Nacetylsulfamethoxazol (NACS)) were ...
Akunna, Joseph C.   +3 more
core   +3 more sources

Influência da circulação extracorpórea sobre as concentrações plasmáticas de atenolol Influence of cardiopulmonary bypass on the plasma concentrations of atenolol

open access: yesArquivos Brasileiros de Cardiologia, 2007
FUNDAMENTO: Os betabloqueadores são usados no tratamento da angina pectoris e outras doenças coronarianas isquêmicas, reduzindo mortalidade e eventos cardiovasculares.
Fátima da Silva Leite   +8 more
doaj   +1 more source

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Introduction: Hypertension, “The silent killer” is a multifactorial disorder which is asymptomatic and if left untreated leads to lethal complications.
Vivek V. Bhosale   +5 more
doaj   +1 more source

Prediction of In Vivo Atenolol Removal by High-Permeability Hemodialysis Based on an In Vitro Model

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2013
Purpose. In order to update our data on drug dialyzability using the high-permeability dialysis membranes, atenolol elimination by an in vitro dialysis model was compared to that observed in six patients during high-permeability hemodialysis (HD), and ...
Kahina Daheb   +4 more
doaj   +1 more source

Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study

open access: yesJPRAS Open, 2022
Summary: Propranolol is the first-line agent for the treatment of infantile haemangioma (IH). Due to its non-selective beta blockade respiratory adverse events are commonplace.
Sasha Wilson   +3 more
doaj   +1 more source

Cardio-Protection Afforded by Β-Blockade Is Maintained During Resistance Exercise [PDF]

open access: yes, 2017
Objectives Whether or not the cardio-protective effect of β-adrenergic blockade is retained during resistance exercise has not been systematically evaluated.
Conviser, Jason M.   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy